AxoGen Company Profile (NASDAQ:AXGN)

About AxoGen (NASDAQ:AXGN)

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Appliances & Equipment
Sub-Industry: N/A
Symbol: NASDAQ:AXGN
CUSIP: N/A
Web: www.axogeninc.com

Capitalization:

Market Cap: $541.11 million
Outstanding Shares: 33,095,000

Average Prices:

50 Day Moving Avg: $15.83
200 Day Moving Avg: $12.51
52 Week Range: $6.45 - $17.25

P/E:

Trailing P/E Ratio: N/A
Foreward P/E Ratio: -232.14
P/E Growth: 0.00

Sales & Book Value:

Annual Revenue: $45.24 million
Price / Sales: 11.89
Book Value: $0.37 per share
Price / Book: 43.92

Profitability:

EBIDTA: ($8,230,000.00)
Net Margins: -32.05%
Return on Equity: -155.78%
Return on Assets: -31.67%

Debt:

Debt-to-Equity Ratio: 1.67%
Current Ratio: 3.83%
Quick Ratio: 3.28%

Misc:

Average Volume: 209,933 shs.
Beta: 0.27
Short Ratio: 6.09

Frequently Asked Questions for AxoGen (NASDAQ:AXGN)

What is AxoGen's stock symbol?

AxoGen trades on the NASDAQ under the ticker symbol "AXGN."

How were AxoGen's earnings last quarter?

AxoGen, Inc. (NASDAQ:AXGN) announced its quarterly earnings data on Thursday, May, 4th. The company reported ($0.11) EPS for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.01. The firm earned $12.24 million during the quarter, compared to the consensus estimate of $11.83 million. AxoGen had a negative return on equity of 155.78% and a negative net margin of 32.05%. View AxoGen's Earnings History.

When will AxoGen make its next earnings announcement?

AxoGen is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for AxoGen.

Where is AxoGen's stock going? Where will AxoGen's stock price be in 2017?

5 equities research analysts have issued 12-month target prices for AxoGen's stock. Their predictions range from $11.00 to $18.00. On average, they expect AxoGen's share price to reach $14.38 in the next year. View Analyst Ratings for AxoGen.

Who are some of AxoGen's key competitors?

Some companies that are related to AxoGen include Eagle Pharmaceuticals (EGRX), Cardiovascular Systems (CSII), Insmed (INSM), Acorda Therapeutics (ACOR), Forward Pharma A/S (FWP), OraSure Technologies (OSUR), Surgery Partners (SGRY), NeuroDerm (NDRM), BioTelemetry (BEAT), Community Health Systems (CYH), Omeros Corporation (OMER), Mazor Robotics (MZOR), Kindred Healthcare (KND), Aduro Biotech (ADRO), Immunomedics (IMMU), Irhythm Tech (IRTC), Synergy Pharmaceuticals (SGYP) and Cellectis S.A. (CLLS).

Who owns AxoGen stock?

AxoGen's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (1.85%), Perkins Capital Management Inc. (1.68%), Pennsylvania Trust Co (0.17%), Campbell & CO Investment Adviser LLC (0.06%) and Bank of Montreal Can (0.05%). Company insiders that own AxoGen stock include Amy Mcbride Wendell, James E Flynn, John P Engels, Joseph M Mandato, Karen L Zaderej and Peter J Mariani. View Institutional Ownership Trends for AxoGen.

Who sold AxoGen stock? Who is selling AxoGen stock?

AxoGen's stock was sold by a variety of institutional investors in the last quarter, including Pennsylvania Trust Co and Perkins Capital Management Inc.. View Insider Buying and Selling for AxoGen.

Who bought AxoGen stock? Who is buying AxoGen stock?

AxoGen's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Campbell & CO Investment Adviser LLC. Company insiders that have bought AxoGen stock in the last two years include Amy Mcbride Wendell, John P Engels, Karen L Zaderej and Peter J Mariani. View Insider Buying and Selling for AxoGen.

How do I buy AxoGen stock?

Shares of AxoGen can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AxoGen's stock price today?

One share of AxoGen stock can currently be purchased for approximately $16.25.

MarketBeat Community Rating for AxoGen (NASDAQ AXGN)

Community Ranking:		3.5 out of 5 ( )
Outperform Votes:		69 (Vote Outperform)
Underperform Votes:		29 (Vote Underperform)
Total Votes:		98

MarketBeat's community ratings are surveys of what our community members think about AxoGen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for AxoGen (NASDAQ:AXGN) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	5 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$14.38 (11.54% downside)

Analysts' Ratings History for AxoGen (NASDAQ:AXGN)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
6/29/2017	Cantor Fitzgerald	Initiated Coverage	Overweight -> Overweight	$18.00	High
5/19/2017	Wedbush	Reiterated Rating	Outperform	$17.00 -> $14.00	High
3/6/2017	Roth Capital	Initiated Coverage	Buy -> Buy	$14.50	N/A
11/22/2016	JMP Securities	Reiterated Rating	Buy		N/A
11/22/2016	Lake Street Capital	Upgrade	Hold -> Buy	$9.00 -> $11.00	N/A

(Data available from 7/27/2015 forward)

Earnings History for AxoGen (NASDAQ:AXGN)

Earnings by Quarter for AxoGen (NASDAQ:AXGN)

Earnings History by Quarter for AxoGen (NASDAQ AXGN)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/2/2017		($0.08)					N/A
5/4/2017	Q1 2017	($0.10)	($0.11)	$11.83 million	$12.24 million	View	Listen
2/22/2017	Q4 2016	($0.09)	($0.10)		$11.41 million	View	Listen
11/2/2016	Q3 2016	($0.08)	($0.08)	$11.21 million	$11.21 million	View	N/A
8/3/2016	Q2	($0.12)	($0.09)	$9.28 million	$10.38 million	View	N/A
11/5/2015	Q3 2015	($0.12)	($0.11)	$6.70 million	$8.15 million	View	N/A
8/6/2015	Q2 2015	($0.15)	($0.13)	$5.89 million	$6.42 million	View	N/A
5/5/2015	Q1 2015	($0.17)	($0.16)	$4.90 million	$4.95 million	View	N/A
11/13/2014	Q3 2014	($0.24)	($0.19)		$4.67 million	View	N/A
8/4/2014	Q2 2014	($0.22)	($0.21)	$3.30 million	$4.21 million	View	N/A
4/30/2014	Q1 2014	($0.26)	($0.24)	$2.75 million	$3.14 million	View	N/A
3/6/2014		($0.22)	($0.24)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for AxoGen (NASDAQ:AXGN)

2017 EPS Consensus Estimate: ($0.25)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	3	($0.12)	($0.07)	($0.10)
Q2 2017	3	($0.06)	($0.04)	($0.05)
Q3 2017	3	($0.05)	($0.03)	($0.04)
Q4 2017	3	($0.09)	($0.04)	($0.06)
Q1 2018	1	$0.01	$0.01	$0.01
Q2 2018	1	$0.03	$0.03	$0.03
Q3 2018	1	$0.04	$0.04	$0.04

(Data provided by Zacks Investment Research)

Dividend History for AxoGen (NASDAQ:AXGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for AxoGen (NASDAQ:AXGN)

Insider Ownership Percentage: 9.33%
Institutional Ownership Percentage: 63.49%

Institutional Ownership by Quarter for AxoGen (NASDAQ:AXGN)

Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
10/7/2016	Amy Mcbride Wendell	Director	Buy	13,333	$7.50	$99,997.50
10/7/2016	John P Engels	VP	Buy	4,000	$7.50	$30,000.00
10/7/2016	Karen L Zaderej	CEO	Buy	10,000	$7.50	$75,000.00
10/7/2016	Peter J Mariani	CFO	Buy	3,333	$7.50	$24,997.50
8/9/2016	Joseph M Mandato	Director	Sell	149,618	$8.54	$1,277,737.72
8/8/2016	Joseph M Mandato	Director	Sell	107,450	$8.63	$927,293.50
7/21/2016	James E Flynn	Insider	Sell	102,136	$6.70	$684,311.20
7/18/2016	James E Flynn	Insider	Sell	279,303	$7.53	$2,103,151.59
9/18/2015	James E Flynn	Insider	Sell	345,000	$5.50	$1,897,500.00
6/3/2015	Joseph M Mandato	Director	Buy	6,500	$3.10	$20,150.00
6/2/2015	Lee Robert Johnston Jr	Insider	Buy	5,000	$3.06	$15,300.00
4/8/2015	James E Flynn	Insider	Sell	144,385	$3.25	$469,251.25
12/10/2014	Lee Robert Johnston Jr	CFO	Buy	10,000	$3.06	$30,600.00
8/12/2014	Mark Stephen Gold	Director	Buy	20,000	$2.29	$45,800.00
8/8/2014	Mark Stephen Gold	Director	Buy	11,000	$2.31	$25,410.00
6/6/2014	Lee Robert Johnston Jr	CFO	Buy	10,000	$2.58	$25,800.00
6/3/2014	Gregory Gene Freitag	CFO	Buy	5,200	$2.45	$12,740.00
6/3/2014	Karen L Zaderej	CEO	Buy	5,000	$2.43	$12,150.00
5/20/2014	Jill F Schiaparelli	SVP	Buy	2,000	$2.63	$5,260.00
5/12/2014	Karen L Zaderej	CEO	Buy	5,000	$2.70	$13,500.00
5/7/2014	Mark Stephen Gold	Director	Buy	1,977	$2.60	$5,140.20
3/13/2014	Karen L Zaderej	CEO	Buy	1,500	$3.49	$5,235.00
8/29/2013	Shawn F Mccarrey	SVP	Buy	25,000	$3.21	$80,250.00
8/24/2013	Shawn F Mccarrey	SVP	Buy	5,000	$3.00	$15,000.00
8/14/2013	Jill F Schiaparelli	SVP	Buy	5,000	$3.00	$15,000.00
8/14/2013	John Frederick Harper	Director	Buy	66,666	$3.00	$199,998.00
8/14/2013	Karen L Zaderej	CEO	Buy	8,334	$3.00	$25,002.00
12/4/2012	Jill F Schiaparelli	SVP	Buy	2,000	$2.55	$5,100.00
11/29/2012	Jill F Schiaparelli	SVP	Buy	1,000	$2.70	$2,700.00
11/15/2012	Jill F Schiaparelli	SVP	Buy	2,750	$2.56	$7,040.00
10/1/2012	John Frederick Harper	Director	Buy	86,557	$3.61	$312,470.77

(Data available from 1/1/2013 forward)

Headline Trends for AxoGen (NASDAQ:AXGN) Latest Headlines for AxoGen (NASDAQ:AXGN)

Source:

Date	Headline
	AxoGen, Inc. (AXGN) Set to Announce Quarterly Earnings on Wednesday www.americanbankingnews.com - July 26 at 7:56 AM
	AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Buy" by Brokerages www.americanbankingnews.com - July 25 at 8:24 AM
	Zacks: Brokerages Anticipate AxoGen, Inc. (NASDAQ:AXGN) Will Post Quarterly Sales of $14.40 Million www.americanbankingnews.com - July 22 at 8:00 AM
	Analysts Anticipate AxoGen, Inc. (NASDAQ:AXGN) to Post -$0.08 EPS www.americanbankingnews.com - July 20 at 10:18 PM
	AxoGen, Inc. Discloses Terms of Recent Equity Award finance.yahoo.com - July 20 at 5:44 PM
	Globus Medical (GMED) & AxoGen (NASDAQ:AXGN) Critical Review www.americanbankingnews.com - July 20 at 5:21 PM
	AxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, www.nasdaq.com - July 19 at 5:29 PM
	AxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 2, 2017 finance.yahoo.com - July 19 at 5:29 PM
	Integer Holdings (ITGR) & AxoGen (NASDAQ:AXGN) Head to Head Analysis www.americanbankingnews.com - July 16 at 12:26 PM
	Comparing Sunshine Heart (SSH) & AxoGen (NASDAQ:AXGN) www.americanbankingnews.com - July 16 at 12:28 AM
	Reviewing Sunshine Heart (SSH) and AxoGen (NASDAQ:AXGN) www.americanbankingnews.com - July 15 at 10:04 PM
	Reviewing Globus Medical (GMED) and AxoGen (NASDAQ:AXGN) www.americanbankingnews.com - July 15 at 8:07 AM
	AxoGen, Inc. (NASDAQ:AXGN) Forecasted to Earn FY2017 Earnings of ($0.30) Per Share www.americanbankingnews.com - July 6 at 9:38 AM
	AxoGen, Inc. (AXGN) Receives Consensus Rating of "Buy" from Analysts www.americanbankingnews.com - June 29 at 6:40 PM
	AxoGen, Inc. (AXGN) Receives New Coverage from Analysts at Cantor Fitzgerald www.americanbankingnews.com - June 29 at 6:02 PM
	AxoGen (AXGN) & Integer Holdings (ITGR) Head to Head Review www.americanbankingnews.com - June 29 at 8:05 AM
	$14.40 Million in Sales Expected for AxoGen, Inc. (AXGN) This Quarter www.americanbankingnews.com - June 28 at 10:34 AM
	AxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.08 Per Share www.americanbankingnews.com - June 26 at 6:38 PM
	AxoGen (AXGN) Presents at JMP Securities Life Sciences Conference 2017 - Slideshow seekingalpha.com - June 22 at 3:52 PM
	AxoGen, Inc. (AXGN) Rating Increased to Hold at ValuEngine www.americanbankingnews.com - June 12 at 10:58 PM
	ETFs with exposure to AxoGen, Inc. : June 8, 2017 finance.yahoo.com - June 8 at 4:29 PM
	AxoGen, Inc. to Present at the JMP Securities Life Sciences Conference finance.yahoo.com - June 7 at 7:41 AM
	AxoGen, Inc. (AXGN) finance.yahoo.com - June 5 at 12:59 PM
	Zacks: Brokerages Expect AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $14.40 Million www.americanbankingnews.com - June 2 at 1:16 PM
	-$0.07 EPS Expected for AxoGen, Inc. (AXGN) This Quarter www.americanbankingnews.com - May 31 at 2:26 PM
	AxoGen's (AXGN) CEO Karen Zaderej Hosts 2017 Annual Shareholders' Meeting (Transcript) seekingalpha.com - May 25 at 2:08 AM
	AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session finance.yahoo.com - May 22 at 10:08 AM
	AxoGen (AXGN): Management Meeting Highlights New Opportunity - Wedbush www.streetinsider.com - May 19 at 9:21 AM
	Wedbush Reaffirms Outperform Rating for AxoGen, Inc. (AXGN) www.americanbankingnews.com - May 19 at 7:42 AM
	ETFs with exposure to AxoGen, Inc. : May 15, 2017 finance.yahoo.com - May 15 at 4:16 PM
	AxoGen, Inc. :AXGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 finance.yahoo.com - May 10 at 3:58 PM
	FY2019 EPS Estimates for AxoGen, Inc. Raised by Wedbush (AXGN) www.americanbankingnews.com - May 8 at 12:12 PM
	AxoGen, Inc. (AXGN) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS www.americanbankingnews.com - May 5 at 3:58 PM
	Zacks: Brokerages Anticipate AxoGen, Inc. (AXGN) to Announce -$0.05 EPS www.americanbankingnews.com - May 5 at 2:25 PM
	AxoGen, Inc. Reports 2017 First Quarter Financial Results finance.yahoo.com - May 4 at 8:55 PM
	AxoGen reports 1Q loss finance.yahoo.com - May 4 at 8:55 PM
	Investor Network: AxoGen, Inc. to Host Earnings Call finance.yahoo.com - May 4 at 3:53 PM
	ETFs with exposure to AxoGen, Inc. : May 2, 2017 finance.yahoo.com - May 3 at 11:52 AM
	Somewhat Negative News Coverage Very Likely to Affect AxoGen (AXGN) Stock Price www.americanbankingnews.com - May 2 at 6:10 PM
	AxoGen, Inc. (AXGN) Set to Announce Earnings on Thursday www.americanbankingnews.com - May 2 at 10:24 AM
	Somewhat Negative News Coverage Extremely Likely to Affect AxoGen (AXGN) Stock Price www.americanbankingnews.com - April 29 at 11:14 AM
	AxoGen (AXGN) Given News Sentiment Rating of 0.56 www.americanbankingnews.com - April 24 at 1:00 PM
	Somewhat Positive Press Coverage Very Likely to Affect AxoGen (AXGN) Stock Price www.americanbankingnews.com - April 21 at 11:39 AM
	AxoGen (AXGN) Earning Somewhat Positive Media Coverage, AlphaOne Reports www.americanbankingnews.com - April 18 at 12:20 PM
	ETFs with exposure to AxoGen, Inc. : April 17, 2017 finance.yahoo.com - April 17 at 3:42 PM
	AxoGen, Inc. (AXGN) Short Interest Up 2.0% in March www.americanbankingnews.com - April 17 at 10:48 AM
	AxoGen, Inc. (AXGN) Expected to Post Quarterly Sales of $11.83 Million www.americanbankingnews.com - April 16 at 8:38 AM
	AxoGen (AXGN) Receiving Favorable Media Coverage, Report Shows www.americanbankingnews.com - April 15 at 10:55 AM
	AxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.10 Per Share www.americanbankingnews.com - April 14 at 4:32 PM
	AxoGen, Inc. to Report First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017 finance.yahoo.com - April 14 at 11:19 AM